Home/ Supplements/ Vitamin K/ Vitamin K1 100 mcg

Vitamin K1 100 mcg

product on market Tablet or Pill Country Life Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K1 is essential for the synthesis of proteins required for blood coagulation and bone mineralization. There is strong evidence supporting its role in maintaining proper clotting functions and skeletal health. This ingredient profile is generally considered safe for most healthy individuals.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K1 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Cellulose Stearic Acid Cellulose & Glycerin Coating Magnesium Stearate Vegetable Glaze
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: Adults take one (1) tablet daily with food. Do not exceed recommended dose.

Warnings & Precautions

As a reminder, discuss supplements and medications that you take with your health care providers.

Caution: If you are pregnant or nursing, taking medication (especially anti-coagulants, blood thinners) or planning a surgery, consult your doctor before using this product.

If any adverse reactions occur, stop taking the product and consult your doctor.

Do not accept if seal is broken.

Keep out of reach of children.

Formulation Notes

Dark leafy vegetables contain phytonadione, a form of Vitamin K.

Yes Certified Gluten-Free by GFCO.ORG

Yes Certified Vegan by the AVA

Yes Kosher-Parve

No Yeast, Wheat or Corn No Soy or Milk No Salt or Sugar No Preservatives No Artificial Colors, Flavors or Sweeteners

Certified Gluten-Free

Additional Information

This product has been manufactured at a GMP Registered facility.

This form of Vitamin K is essential and used in the body to support bone and blood health.

Yes Recycling Packaging Yes Manufacturing Supports Wind Power

K Parve

Established 1971

~ Supports bone health ~ K1 naturally found in food

Our Pledge of Integrity Authenticity ~ Cleanliness ~ Freshness Consistency ~ Accuracy

Product No. 8011 05H16NL

Store in a dry place between 59(0)-86(0) F.

Metadata

Product Details

UPC / SKU0 15794 08011 4
DSLD Entry Date2016-09-22
Product TypeVitamin
FormTablet or Pill
DSLD ID64974
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.